Exploring daily movement behaviors in patients with type 2 diabetes
Official title: 24-hour Movement Behaviors Among Type 2 Diabetes Mellitus Patients
Run by University Hospital, Ghent · NCT04993482 · Data updated 2026-11-12
This study looks at how people with type 2 diabetes move throughout the day to see how their activity levels affect their health and to help create better lifestyle tips for managing the condition.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 100 Years |
| Sex | All |
| Enrollment | 248 (estimated) |
| Sponsor | University Hospital, Ghent Academic / other |
| Locations | 1 site (Ghent) |
| Status | Recruiting |
| Started | August 29, 2021 |
| Main results expected | December 1, 2026 |
| Study ends | December 1, 2026 |
| Registry record updated | December 8, 2023 |
| Trial ID | NCT04993482 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults over 18 years old diagnosed with type 2 diabetes mellitus.
✕Probably not a fit
Patients with type 1 diabetes, certain physical or cognitive disabilities, or other severe health conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study investigates the 24-hour movement behavior patterns among patients with type 2 diabetes mellitus (T2DM) over a two-year period. It compares these patterns with a healthy control group and examines associations with personal and environmental factors, as well as cardiometabolic markers. The goal is to gain insights into how different movement behaviors impact T2DM management and to lay the groundwork for future interventions. By understanding these behaviors collectively rather than in isolation, the study aims to inform better lifestyle recommendations for T2DM patients.
Why it matters
Potential benefit: If successful, this study could lead to improved lifestyle recommendations that enhance the management of type 2 diabetes.
How similar studies have gone: Other studies have shown success in examining lifestyle behaviors in diabetes management, but this comprehensive 24-hour approach is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion criteria T2DM patients * Adults aged \>18 years old * Diagnosed with T2DM by a physician or an HbA1C above 6.5% Exclusion criteria T2DM patients * Diagnosed with type 1 diabetes mellitus (T1DM) * Diagnosed with pregnancy diabetes * Diagnosed with latent autoimmune diabetes in adults (LADA) * Physical disabilities that obstruct the normal PA pattern (e.g. amputations, paralysis) * Cognitive disabilities that obstruct daily functioning (e.g. dementia, psychological disorders) * Other conditions affecting the normal PA pattern (e.g. heart failure NYHA class 3 and 4, chronic respiratory diseases (COPD stage 4), end stage nonalcoholic fatty liver disease, end stage renal failure, cancer, hospitalized) * Pregnancy or pregnancy \<1 year ago * Participating in a physical activity intervention Inclusion criteria control participants \- Adults aged \> 18 years old Exclusion criteria control participants * Diagnosed with T2DM * Diagnosed with T1DM * Diagnosed with pregnancy diabetes * Diagnosed with LADA * Physical disabilities that obstruct the normal PA pattern (e.g. amputations, paralysis) * Cognitive disabilities that obstruct daily functioning (e.g. dementia, psychological disorders) * Other conditions affecting the normal PA pattern (e.g. heart failure NYHA class 3 and 4, chronic respiratory diseases (COPD stage 4), end stage nonalcoholic fatty liver disease, end stage renal failure, cancer, hospitalized) * Pregnancy or pregnancy \<1 year ago * Participating in a physical activity intervention
Where it's running
-
Ghent University Hospital, Dept. of Endocrinology
Ghent, Belgium Recruiting
Study contacts
- Principal investigator: Bruno Lapauw, Professor — Ghent University Hospital - endocrinologist
- Study coordinator: Iris Willems, PhD student
- Email: willems.iris@ugent.be
- Phone: 093323638
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Proliverenol for liver fat and insulin resistance in type 2 diabetes
This study tests whether adding Proliverenol to standard diabetes care can improve liver fat and blood sugar control in adults with type 2 diabetes.
-
Whole-Body Vibration Training in Women With Obesity With and Without Type 2 Diabetes
This study tests whether eight weeks of supervised whole-body vibration training changes ankle muscle activity and walking performance in women with obesity, comparing those with and without type 2 diabetes.
-
Safety test of NNC9836-0001 in adults with overweight/obesity or type 2 diabetes
This study tests whether the new medicine NNC9836-0001 is safe and tolerable in adults who are overweight or have type 2 diabetes, compared to placebo.
-
RIGHTEST iFree 2 CGM in Pregnant Women With Diabetes
This study tests the accuracy and safety of the RIGHTEST iFree 2 continuous glucose monitor in pregnant adults with type 1, type 2, or gestational diabetes.
-
EloraTZP for weight loss in adults with overweight/obesity and type 2 diabetes
This trial tests whether a coformulation of eloralintide and tirzepatide helps people with obesity or overweight and type 2 diabetes lose weight compared with tirzepatide alone.
-
Maridebart cafraglutide vs. semaglutide for type 2 diabetes on metformin
This trial tests whether maridebart cafraglutlide is as good as semaglutide at improving blood sugar in adults with type 2 diabetes who take metformin (with or without an SGLT-2 inhibitor).
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.